With up to a quarter of US children and adolescents affected by a chronic condition, Sinead Ni Mhurchadha and Anna O’Sullivan stress the importance of understanding their needs and developing t
The EMA's human medicines committee has recommended against approval of Eisai and Biogen's Alzheimer's disease therapy Leqembi, after regulators in the US, China and Japan gave a green ligh